| 摘要 |
PURPOSE:To obtain a nootropic having anti-dementia action and low toxicity, containing a triazine derivative or a salt thereof as a main component. CONSTITUTION:A triazine derivative shown by formula I (R<1> is H or lower alkyl; R<2> and R<3> are lower alkoxy, H or halogen) or a salt thereof as a main component is blended with a conventional drug carrier and pharmaceutically manufactured by a conventional procedure to give the aimed substance. The substance can be medicated by oral administration, administration in tissue, local administration (percutaneous administration) or administration through the rectum and can be prepared into a dosage form suitable for these administrations. A dose is 0.1-30mg, preferably 1-10mg calculated as the amount of the active ingredient per adult daily and administered preferably dividedly one-three times. The compound shown by the formula has antiulcer action, is a well-known compound and newly found to have nootropic action.
|
